Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (271-280 of 305) with videos related to

Pageof 31
Sort By:
Journal of the American College of Cardiology|November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary StentingAnna Franzone, Eugène McFadden, Sergio Leonardi, et al.
International Journal of Cardiology|April 20, 2023
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHTAlessandro Spirito, Marco Valgimigli, Davide Cao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 18, 2019
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access TrialGiuseppe Gargiulo, Sara Ariotti, Pascal Vranckx, et al.
Journal of the American College of Cardiology|November 19, 2021
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIMarco Valgimigli, Davide Cao, Dominick J Angiolillo, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 4, 2021
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX scorePly Chichareon, David van Klaveren, Rodrigo Modolo, et al.
Pageof 31

Showing results (271-280 of 305) with videos related to

Sort By:
Pageof 31
Journal of the American College of Cardiology|November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary StentingAnna Franzone, Eugène McFadden, Sergio Leonardi, et al.
International Journal of Cardiology|April 20, 2023
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHTAlessandro Spirito, Marco Valgimigli, Davide Cao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 18, 2019
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access TrialGiuseppe Gargiulo, Sara Ariotti, Pascal Vranckx, et al.
Journal of the American College of Cardiology|November 19, 2021
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIMarco Valgimigli, Davide Cao, Dominick J Angiolillo, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 4, 2021
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX scorePly Chichareon, David van Klaveren, Rodrigo Modolo, et al.
Pageof 31